HK1013818A1 - Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives - Google Patents

Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives

Info

Publication number
HK1013818A1
HK1013818A1 HK98115181A HK98115181A HK1013818A1 HK 1013818 A1 HK1013818 A1 HK 1013818A1 HK 98115181 A HK98115181 A HK 98115181A HK 98115181 A HK98115181 A HK 98115181A HK 1013818 A1 HK1013818 A1 HK 1013818A1
Authority
HK
Hong Kong
Prior art keywords
benzodiazepine derivatives
stereoselective process
producing dihydro
dihydro
producing
Prior art date
Application number
HK98115181A
Other languages
English (en)
Inventor
Benjamin Anderson
Marvin Martin Hansen
Jeffrey Thomas Vicenzi
David Lee Varie
Milton Joseph Zmijewski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/413,036 external-priority patent/US5665878A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK1013818A1 publication Critical patent/HK1013818A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98115181A 1994-08-31 1998-12-23 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives HK1013818A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US08/413,036 US5665878A (en) 1994-08-31 1995-03-28 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
HK1013818A1 true HK1013818A1 (en) 1999-09-10

Family

ID=26970799

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98115181A HK1013818A1 (en) 1994-08-31 1998-12-23 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives

Country Status (22)

Country Link
US (3) US5919954A (de)
EP (1) EP0699677B1 (de)
JP (1) JP3481019B2 (de)
KR (1) KR100399518B1 (de)
CN (1) CN1086705C (de)
AT (1) ATE231867T1 (de)
AU (1) AU702658B2 (de)
BR (1) BR9503845A (de)
CA (1) CA2157234C (de)
CZ (1) CZ295675B6 (de)
DE (1) DE69529499T2 (de)
DK (1) DK0699677T3 (de)
ES (1) ES2189819T3 (de)
FI (1) FI113269B (de)
HK (1) HK1013818A1 (de)
HU (1) HU223776B1 (de)
IL (1) IL115100A (de)
IN (1) IN190402B (de)
NO (1) NO312838B1 (de)
PL (3) PL190318B1 (de)
RU (1) RU2151149C1 (de)
TR (1) TR199501071A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK1792000A3 (en) * 1997-08-12 2000-09-12 Egyt Gyogyszervegyeszeti Gyar 1,3-DIOXOLO(4,5-H)(2,3)BENZODIAZEPINE DERIVATIVES, PROCESS FORì (54) THE PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION CO
UA67749C2 (uk) 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
WO1999023242A1 (en) * 1997-11-04 1999-05-14 Eli Lilly And Company Ketoreductase gene and protein from yeast
US20030219456A1 (en) * 2002-05-21 2003-11-27 Taing Ok Method of utilization of zygosaccharomyces rouxii
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
ES2322069T3 (es) * 2005-12-05 2009-06-16 Deutsche Post Ag Procedimiento para la clasificacion de envios postales y dispositivo con una estructura de datos para un plan de clasificacion.
EP1979308A1 (de) * 2005-12-30 2008-10-15 EGIS Gyógyszergyár Nyrt Optische isomere von dihydro-2,3-benzodiazepinen und ihre stereoselektive synthese
KR100841592B1 (ko) 2007-04-16 2008-06-26 한양대학교 산학협력단 벤조디옥솔 유도체와 이의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794642A (en) * 1973-01-15 1974-02-26 Lilly Co Eli Oxidation of substituted methanes to the corresponding substituted methanols
DE2816475A1 (de) * 1978-04-15 1979-10-25 Bayer Ag Isochroman-derivate, verfahren zu ihrer herstellung und ihre verwendung als synergisten in insektiziden und akariziden mitteln
US4358041A (en) 1980-06-12 1982-11-09 Olin Corporation Powder-actuated tool with power adjustment and angle-fire control
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU198494B (en) 1986-08-15 1989-10-30 Gyogyszerkutato Intezet Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same
DE68926417T2 (de) * 1988-02-12 1996-09-12 Daicel Chem Verfahren zur herstellung von optisch aktiven 2-hydroxysäureabkömmlingen
JP2679145B2 (ja) * 1988-09-02 1997-11-19 ダイセル化学工業株式会社 オキシケトンの製造法
HU206719B (en) 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
JP3061422B2 (ja) * 1990-12-27 2000-07-10 ダイセル化学工業株式会社 光学活性（ｓ）−２−クロロ−１−フェニルプロパノールの製造法
JPH04271789A (ja) * 1991-01-10 1992-09-28 Takeda Chem Ind Ltd Ｄ−パントラクトンの製造方法
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
KR960007595A (ko) 1996-03-22
CA2157234C (en) 2005-05-03
PL190318B1 (pl) 2005-11-30
CN1086705C (zh) 2002-06-26
HUT72644A (en) 1996-05-28
CA2157234A1 (en) 1996-03-01
EP0699677B1 (de) 2003-01-29
BR9503845A (pt) 1996-04-16
DE69529499D1 (de) 2003-03-06
HU9502545D0 (en) 1995-10-30
EP0699677A1 (de) 1996-03-06
NO312838B1 (no) 2002-07-08
IL115100A (en) 2000-07-26
NO953396D0 (no) 1995-08-30
KR100399518B1 (ko) 2004-04-30
RU2151149C1 (ru) 2000-06-20
FI954064A (fi) 1996-03-01
AU702658B2 (en) 1999-02-25
US6160133A (en) 2000-12-12
DK0699677T3 (da) 2003-04-22
JP3481019B2 (ja) 2003-12-22
IL115100A0 (en) 1995-12-08
US5986114A (en) 1999-11-16
CZ221995A3 (en) 1996-03-13
PL310226A1 (en) 1996-03-04
AU3035595A (en) 1996-03-14
CZ295675B6 (cs) 2005-09-14
FI954064A0 (fi) 1995-08-30
ES2189819T3 (es) 2003-07-16
DE69529499T2 (de) 2003-12-04
ATE231867T1 (de) 2003-02-15
PL188796B1 (pl) 2005-04-29
TR199501071A2 (tr) 1996-06-21
JPH0881468A (ja) 1996-03-26
NO953396L (no) 1996-03-01
CN1123282A (zh) 1996-05-29
IN190402B (de) 2003-07-26
PL190640B1 (pl) 2005-12-30
FI113269B (fi) 2004-03-31
HU223776B1 (hu) 2005-01-28
US5919954A (en) 1999-07-06

Similar Documents

Publication Publication Date Title
TW221285B (de)
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
HU911771D0 (en) Process for producing substituted and heterocyclic phthalides
HU913792D0 (en) Method for producing serotonine antagonists
IL134905A0 (en) Novel intermediates for endothelin antagonistic pyrrolidine derivatives
HU9502545D0 (en) Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives
MY117754A (en) Stereoselective process for producing dihydro-2, 3-benzodiazepine derivatives
HUT68267A (en) Process for producing imidazo-pyridine derivatives
MX9706744A (es) Proceso novedosos para preparar derivados de 2,3-dihidro-benzofuranol.
MA23268A1 (fr) Procede de preparation de composes azacyliques heterocycliques utiles comme antagonistes des recepteurs d'natagonisne ii.
AU3210593A (en) Improvements in or relating to organic compounds
PT85570A (fr) Procede de preparation de derives de 2,3-dihydro furanne utilisables comme intermediaires pour la preparation de tetrahydrofuranne
HUP0001700A2 (en) Process for the production of 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4h-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
ES2095032T3 (es) Derivados 2- y 3-amino y azido de 1,5-iminoazucares como compuestos antivirales.
HU9702338D0 (en) Process for producing intermediates of 1,4-dihydro-pyridine-3,5-dicarboxylic acid derivatives and the intermediate compounds

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110830